TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
KNSA

Kiniksa Pharmaceuticals Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

75.70$ -0.5% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Kiniksa Pharmaceuticals Ltd (KNSA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 764 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KNSA
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
56 47 322 255 349 233 460 526 581 764
56 47 314 242 333 196 243 276 332 527
56 46 307 47 114 122 123 108 184 166
56 46 307 233 323 182 191 206 244 414
– – – – 0.0 4.0 20 21 42 16
– – – – 0.0 3.7 22 31 26 55
0.1 0.1 6.4 8.3 4.1 2.8 1.7 – – –
– – – – – 19 18 17 16 15
82 137 43 29 38 48 64 87 142 196
2.3 17 43 28 32 45 47 64 101 139
– – – 1.7 2.1 3.4 3.3 2.3 2.0 3.0
0.2 1.2 11 5.7 0.5 1.9 7.9 8.2 2.0 2.0
-26 -90 -194 225 312 185 396 439 438 568
-26 -91 -194 -356 -517 -675 -492 -478 -521 -462
32 32 30 54 62 69 70 72 71 79

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?